Press Releases

 
Press Releases
  Date Title View
Nov 29, 2016
ALBANY, N.Y., Nov. 29, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing, Inc. which product has been in AMRI's portfolio through the required stages of development.  Shire plc, is a leading global biotechnology company focused on de...
Nov 14, 2016
ALBANY, N.Y., Nov. 14, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI), a premier contract services provider to the life sciences industry, will be presenting two posters at the 2016 AAPS Annual Meeting and Exposition, at the Colorado Convention Center in Denver. The posters will showcase data supporting AMRI's innovative approach to solving complex scien...
Nov 8, 2016
ALBANY, N.Y., Nov. 8, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter ended September 30, 2016 and reiterated its outlook for 2016. Highlights: Contract revenue of $151.7 million, up 50% from the third quarter 2015 Reported contract margins of 19%; non-GAAP contract...
Oct 20, 2016
ALBANY, N.Y., Oct. 20, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue third quarter 2016 financial results before the opening of the market on Tuesday, November 8, 2016. Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET. The conference call can...
Oct 3, 2016
ALBANY, N.Y., Oct. 3, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI), a premier contract services provider to the life sciences industry, will be showcasing its comprehensive portfolio of active pharmaceutical ingredients (APIs) and capabilities at CPhI Worldwide, one of the pharmaceutical industry's highest profile events, being held this week in Barcel...
Aug 30, 2016
ALBANY, N.Y., Aug. 30, 2016 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2016 at 3:30 p.m. ET. A live audio webcast of the presentation can be accessed at AMR...
Aug 24, 2016
ALBANY, N.Y., Aug. 24, 2016 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the Baird 2016 Global Healthcare Conference on Wednesday, September 7, 2016 at 1:25 p.m. ET. A live audio webcast of the presentation can be accessed at AMRI's...
Aug 23, 2016
ALBANY, N.Y., Aug. 23, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it entered into a non-exclusive commercial license agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cas9 gene editing technology and has completed several projects for its customers. The company will continue to use the technology to enha...
Aug 4, 2016
ALBANY, N.Y., Aug. 4, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2016 and provided an update to its outlook for 2016. Highlights: Contract revenue of $116.5 million, up 37% from the second quarter 2015 Recurring royalty revenue of $4.4 million ...
Jul 15, 2016
ALBANY, N.Y., July 15, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue second quarter 2016 financial results before the opening of the market on Thursday, August 4, 2016.  Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET. The conference call ca...
Page:
1
... NextLast
= add release to Briefcase